These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16013911)

  • 1. Add-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patients.
    Su TP; Huang CC; Wei IH
    J Clin Psychiatry; 2005 Jul; 66(7):930-7. PubMed ID: 16013911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
    Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
    Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
    Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
    Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
    Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No deterioration of cognitive performance in an aggressive unilateral and bilateral antidepressant rTMS add-on trial.
    Hausmann A; Pascual-Leone A; Kemmler G; Rupp CI; Lechner-Schoner T; Kramer-Reinstadler K; Walpoth M; Mechtcheriakov S; Conca A; Weiss EM
    J Clin Psychiatry; 2004 Jun; 65(6):772-82. PubMed ID: 15291654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial.
    Rossini D; Magri L; Lucca A; Giordani S; Smeraldi E; Zanardi R
    J Clin Psychiatry; 2005 Dec; 66(12):1569-75. PubMed ID: 16401159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral prefrontal rTMS and theta burst TMS as an add-on treatment for depression: a randomized placebo controlled trial.
    Prasser J; Schecklmann M; Poeppl TB; Frank E; Kreuzer PM; Hajak G; Rupprecht R; Landgrebe M; Langguth B
    World J Biol Psychiatry; 2015 Jan; 16(1):57-65. PubMed ID: 25430687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression.
    Fitzgerald PB; Huntsman S; Gunewardene R; Kulkarni J; Daskalakis ZJ
    Int J Neuropsychopharmacol; 2006 Dec; 9(6):655-66. PubMed ID: 16959055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary assessment of the therapeutic efficacy of continuous theta-burst magnetic stimulation (cTBS) in major depression: a double-blind sham-controlled study.
    Chistyakov AV; Kreinin B; Marmor S; Kaplan B; Khatib A; Darawsheh N; Koren D; Zaaroor M; Klein E
    J Affect Disord; 2015 Jan; 170():225-9. PubMed ID: 25261629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression.
    Loo CK; Mitchell PB; Croker VM; Malhi GS; Wen W; Gandevia SC; Sachdev PS
    Psychol Med; 2003 Jan; 33(1):33-40. PubMed ID: 12537034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
    Berlim MT; Van den Eynde F; Daskalakis ZJ
    J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive enhancing effect of rTMS combined with tDCS in patients with major depressive disorder: a double-blind, randomized, sham-controlled study.
    Li X; Liu J; Wei S; Yu C; Wang D; Li Y; Li J; Zhuang W; Luo RC; Li Y; Liu Z; Su Y; Liu J; Xu Y; Fan J; Zhu G; Xu W; Tang Y; Yan H; Cho RY; Kosten TR; Zhou D; Zhang X
    BMC Med; 2024 Jun; 22(1):253. PubMed ID: 38902735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial.
    Rossini D; Lucca A; Zanardi R; Magri L; Smeraldi E
    Psychiatry Res; 2005 Nov; 137(1-2):1-10. PubMed ID: 16225930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durability of the antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) In the absence of maintenance treatment in major depression: a systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials.
    Kedzior KK; Reitz SK; Azorina V; Loo C
    Depress Anxiety; 2015 Mar; 32(3):193-203. PubMed ID: 25683231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression.
    Loo CK; Mitchell PB; McFarquhar TF; Malhi GS; Sachdev PS
    Psychol Med; 2007 Mar; 37(3):341-9. PubMed ID: 17176505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression.
    Berman RM; Narasimhan M; Sanacora G; Miano AP; Hoffman RE; Hu XS; Charney DS; Boutros NN
    Biol Psychiatry; 2000 Feb; 47(4):332-7. PubMed ID: 10686268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression.
    Mantovani A; Aly M; Dagan Y; Allart A; Lisanby SH
    J Affect Disord; 2013 Jan; 144(1-2):153-9. PubMed ID: 22858212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.